HCW Biologics Inc. (NASDAQ: HCWB) Stock Information | RedChip

HCW Biologics Inc. (NASDAQ: HCWB) Listen to this Section


$0.53
+0.0290 ( +5.79% ) 2.5K

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

Market Data


Open


$0.53

Previous close


$0.50

Volume


2.5K

Market cap


$18.91M

Day range


$0.50 - $0.55

52 week range


$0.50 - $2.18

Insider Ownership Transactions

Total Amount Purchased: 5,400.00 | $ 2,862.00

Date Type Amount Purchased Purchaser
2023-09-07 Buy 400.00 Winer Gary M
2023-09-07 Buy 5000.00 Byam Rebecca

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 22, 2024
4 Insider transactions 1 Feb 22, 2024
8-k 8K-related 13 Feb 22, 2024
8-k 8K-related 10 Jan 12, 2024
4 Insider transactions 1 Dec 11, 2023
4 Insider transactions 1 Dec 11, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.